Eli Lilly's weight loss drug dramatically cuts risk of diabetes, company says
![Eli Lilly's weight loss drug dramatically cuts risk of diabetes, company says](https://thehill.com/wp-content/uploads/sites/2/2024/04/GettyImages-2126120123-e1713372235593.jpg?w=900)
Eli Lilly’s antidiabetic medication Zepbound cuts the risk of developing Type 2 diabetes by 94 percent in prediabetic adults and those who are overweight or obese, the company said Tuesday.
Prediabetic and overweight adults who took part in a Phase 3 trial study experienced a significantly reduced risk of progressing to Type 2 diabetes after receiving weekly injections of the medication’s main ingredient tirzepatide over three years compared to those who received a placebo, the company said in a release.
On top of this, adults who received injections with tirzepatide lost weight over their treatment period.
Adults who took 15 mg of tirzepatide — the highest dosage anyone received as part of the study — lost about 23 percent of their body weight by the end of treatment compared to those on the placebo who lost an average of about 2 percent of their body weight.
“The data reinforce the potential clinical benefits of long-term therapy for people living with obesity and pre-diabetes,” said Jeff Emmick, senior vice president of product development at Eli Lilly.
Early results of a late-stage trial, “SURMOUNT-1," were published in the New England Journal of Medicine in 2022. Those results helped the drug receive its Food and Drug Administration approval for weight loss last year.
Eli Lilly submitted data for tirzepatide as a treatment for moderate-to-severe obstructive sleep apnea and obesity to the U.S. Food and Drug Administration earlier this year and plans to submit data on the drug's use for heart failure later this year, the company said in the release.
In the release, Eli Lilly said the overall “tolerability” of tirzepatide in the Phase 3 study was consistent with the primary results of the SURMOUNT-1 study, with the most frequently reported adverse effects being mild to moderate nausea, diarrhea, constipation and vomiting.
Date: |
Topics
-
CNBC - Business
Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
Digital health company Noom is offering compounded GLP-1 drugs to patients in new weight loss program41 minutes ago -
The Wall Street Journal - World
Senators Target Influencers, Telehealth Firms for Misleading Weight-Loss, Other Drug Promotion
The legislation would allow the FDA to warn and fine companies and individuals who post false information online about medications such as Ozempic and Wegovy.1 hour ago -
CNBC - Business
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
Demand for Eli Lilly's Zepbound and Mounjaro has outstripped supply over the last year, forcing the company to invest heavily to increase production.4 hours ago -
The Wall Street Journal - World
Roche Hit as Oral Weight-Loss Drug Candidate Shows Side Effects
Roche’s stock fell after new data from an early-stage clinical trial of its closely watched oral weight-loss drug candidate prompted analysts to question the company’s potential to quickly enter a ...4 hours ago -
NBC News - Top stories
High doses of ADHD drugs linked to a greater risk of psychosis
Taking a high dose of ADHD drugs is linked to more than five times greater risk of developing psychosis or mania, according to a new study published Thursday in the American Journal of Psychiatry.5 hours ago -
The New York Times - Lifestyle
Who Is Nikocado Avocado, the YouTuber Who Revealed Weight Loss?
Nikocado Avocado, a popular vlogger known for his mukbang videos, said he spent the last two years plotting the reveal.17 hours ago
More from The Hill
-
The Hill - Politics
The debate failed on foreign policy
Neither candidate offered any specifics about what foreign and national security policies the U.S. would adopt and implement if he or she takes office in January 2025.14 minutes ago -
The Hill - Politics
Sanders: US moving toward 'oligarchic form of society'
Sen. Bernie Sanders (I-Vt.) said Wednesday that the U.S. is moving toward an “oligarchic form of society" and urged Vice President Harris to make that message more central to her campaign. In doing ...30 minutes ago -
The Hill - Politics
We should all be carbon supremacists
Carbon supremacists should begin by demanding to interact with a human in all transactions, and by making this part of the discussion with our elected and appointed leadership.44 minutes ago -
The Hill - Politics
Republican AG Alberto Gonzales backs Harris, warns against Trump
Former George W. Bush administration Attorney General Alberto Gonzales endorsed Vice President Harris Thursday, citing in part the Supreme Court’s immunity decision in calling former President ...49 minutes ago - Donald Trump -
The Hill - Politics
Koch-affiliated Libre Initiative makes endorsements in Michigan, Connecticut
The Libre Initiative Action is rolling out endorsements for three tight congressional races on Thursday, hoping to win elections to the House and Senate for Republicans in Michigan and Connecticut. ...1 hour ago